Glucotrack, Inc. (GCTK): Nasdaq/NYSE listing notice — GlucoTrack receives Nasdaq extension to May 22, 2023 for compliance with listing rule 5550(b)

Glucotrack, Inc.

Nasdaq granted extension until May 22, 2023 to meet minimum $2.5M stockholders' equity, $35M market value, or $500K net income.
Company was initially notified of noncompliance on November 22, 2022.
Compliance may be achieved through acquisition or equity capital raise on or before May 22, 2023.

item 3.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.95

Glucotrack, Inc. received a nasdaq extension granted notice regarding stockholders equity (rules 5550(b)).

Exchange: nasdaq
Notice: extension granted
Deficiency: stockholders equity
Rules: 5550(b)

Exact text from the filing

February 7, 2023, Nasdaq issued a letter to the Company granting an extension until May 22, 2023 to obtain compliance with the Listing Rule 5550(b) (the “Rule”), which requires a minimum $2,500,000 stockholders’ equity, $35,000,000 market value of listed securities, or $500,000 net income from continuing operations, notice of noncompliance with which was provided by Nasdaq to the Company on November 22, 2022. Nasdaq has granted the Company an extension to comply through either one or both of an acquisition or equity capital raise on or before May 22, 2023.

View on SEC.gov

Browse all listing & compliance notices →

Glucotrack, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-004521

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.